Short and long‐term safety of MP29‐02*: a new therapy for the treatment of allergic rhinitis. (16th July 2013) - Price, David; Bousquet, Jean; Hellings, Peter; Scadding, Glenis; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus